| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-10 17:11:50 UTC |
|---|
| Updated at | 2022-09-10 17:11:50 UTC |
|---|
| NP-MRD ID | NP0303119 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1'r,2s,2's,4's,5s,7's,8'r,9's,12's,13'r,15'r,16'r,18's,19'r)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-5-ylmethyl acetate |
|---|
| Description | [(1'R,2S,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'R,15'R,16'R,18'S,19'R)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]Icosane]-5-yl]methyl acetate belongs to the class of organic compounds known as furospirostanes and derivatives. These are heterocyclic steroids containing a furospirostane moiety, which a skeleton characterized by the presence of a 1,6-dioxaspiro[4.4]Nonane ring system and an androstane moiety. Based on a literature review very few articles have been published on [(1'R,2S,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'R,15'R,16'R,18'S,19'R)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]Icosane]-5-yl]methyl acetate. |
|---|
| Structure | C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4C[C@@H](OC(C)=O)[C@H]5C[C@@H](OC(C)=O)[C@@H](C[C@]5(C)[C@H]4CC[C@]23C)OC(C)=O)O[C@]11CC[C@@](C)(COC(C)=O)O1 InChI=1S/C35H52O10/c1-18-31-29(44-35(18)12-11-32(6,45-35)17-40-19(2)36)14-25-23-13-27(41-20(3)37)26-15-28(42-21(4)38)30(43-22(5)39)16-34(26,8)24(23)9-10-33(25,31)7/h18,23-31H,9-17H2,1-8H3/t18-,23+,24-,25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| [(1'r,2S,2's,4's,5S,7's,8'r,9's,12's,13'r,15'r,16'r,18's,19'r)-15',16',19'-Tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0,.0,.0,]icosane]-5-yl]methyl acetic acid | Generator |
|
|---|
| Chemical Formula | C35H52O10 |
|---|
| Average Mass | 632.7910 Da |
|---|
| Monoisotopic Mass | 632.35605 Da |
|---|
| IUPAC Name | [(1'R,2S,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'R,15'R,16'R,18'S,19'R)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-5-yl]methyl acetate |
|---|
| Traditional Name | (1'R,2S,2'S,4'S,5S,7'S,8'R,9'S,12'S,13'R,15'R,16'R,18'S,19'R)-15',16',19'-tris(acetyloxy)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxolane-2,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-5-ylmethyl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4C[C@@H](OC(C)=O)[C@H]5C[C@@H](OC(C)=O)[C@@H](C[C@]5(C)[C@H]4CC[C@]23C)OC(C)=O)O[C@]11CC[C@@](C)(COC(C)=O)O1 |
|---|
| InChI Identifier | InChI=1S/C35H52O10/c1-18-31-29(44-35(18)12-11-32(6,45-35)17-40-19(2)36)14-25-23-13-27(41-20(3)37)26-15-28(42-21(4)38)30(43-22(5)39)16-34(26,8)24(23)9-10-33(25,31)7/h18,23-31H,9-17H2,1-8H3/t18-,23+,24-,25-,26+,27+,28+,29-,30+,31-,32-,33-,34+,35-/m0/s1 |
|---|
| InChI Key | BEJVBOOFCAJEJN-SVRGIGGVSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as furospirostanes and derivatives. These are heterocyclic steroids containing a furospirostane moiety, which a skeleton characterized by the presence of a 1,6-dioxaspiro[4.4]Nonane ring system and an androstane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Furospirostanes and derivatives |
|---|
| Direct Parent | Furospirostanes and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Furospirostane-skeleton
- Triterpenoid
- Spirostane skeleton
- Steroid ester
- Tetracarboxylic acid or derivatives
- Ketal
- Tetrahydrofuran
- Carboxylic acid ester
- Oxacycle
- Acetal
- Carboxylic acid derivative
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|